Related Experiment Videos
Catabolic mediators as targets for cancer cachexia
Josep M Argilés1, Rodrigo Moore-Carrasco, Sílvia Busquets
1Cancer Research Group, Departament de Bioquímica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Diagonal 645, 08028-Barcelona, Spain.
Drug Discovery Today
|September 10, 2003
Summary
Cancer cachexia, a syndrome of weight loss and malnutrition, involves complex molecular mechanisms. This review explores tumor-induced anorexia and nutrient competition, highlighting potential therapeutic targets for this debilitating condition.
Area of Science:
- Oncology
- Metabolic Medicine
- Molecular Biology
Background:
- Cancer cachexia is a complex syndrome characterized by significant weight loss, anorexia, asthenia, and anemia.
- It is strongly associated with tumor growth, leading to malnutrition due to reduced food intake and increased catabolism.
- The precise cachectic factors remain elusive despite extensive research efforts.
Purpose of the Study:
- To review the molecular mechanisms underlying cancer cachexia.
- To identify and evaluate catabolic mediators, both humoral and tumoral, involved in the syndrome.
- To discuss the potential of these mediators as therapeutic targets for clinical investigation.
Main Methods:
- Literature review of existing scientific studies on cancer cachexia.
- Analysis of molecular pathways and signaling involved in cachexia.
- Evaluation of identified catabolic mediators and their clinical relevance.
Main Results:
- Cancer cachexia involves intricate molecular signaling pathways driven by tumor-associated factors.
- Both host-derived and tumor-derived mediators contribute to anorexia, inflammation, and accelerated catabolism.
- Nutrient competition between the tumor and host exacerbates metabolic disturbances.
Conclusions:
- Understanding the molecular basis of cancer cachexia is crucial for developing effective treatments.
- Targeting specific catabolic mediators presents a promising avenue for future clinical interventions.
- Further research is needed to fully elucidate the complex interplay of factors driving cancer cachexia.